MX371373B - Nalmefeno para reducir el consumo de alcohol en poblaciones especificas. - Google Patents

Nalmefeno para reducir el consumo de alcohol en poblaciones especificas.

Info

Publication number
MX371373B
MX371373B MX2014015488A MX2014015488A MX371373B MX 371373 B MX371373 B MX 371373B MX 2014015488 A MX2014015488 A MX 2014015488A MX 2014015488 A MX2014015488 A MX 2014015488A MX 371373 B MX371373 B MX 371373B
Authority
MX
Mexico
Prior art keywords
nalmefene
reduction
alcohol consumption
specific target
target populations
Prior art date
Application number
MX2014015488A
Other languages
English (en)
Spanish (es)
Other versions
MX2014015488A (es
Inventor
Torup Lars
Abbariki Afsaneh
Bladström Anna
Persson Christine
Meulien Didier
Sørensen Per
Jon Jensen Thomas
Buch Østergaard Jette
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48703496&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX371373(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of MX2014015488A publication Critical patent/MX2014015488A/es
Publication of MX371373B publication Critical patent/MX371373B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
MX2014015488A 2012-06-27 2013-06-27 Nalmefeno para reducir el consumo de alcohol en poblaciones especificas. MX371373B (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261664804P 2012-06-27 2012-06-27
US201261721539P 2012-11-02 2012-11-02
US201261736740P 2012-12-13 2012-12-13
US201361788810P 2013-03-15 2013-03-15
PCT/EP2013/063461 WO2014001427A1 (en) 2012-06-27 2013-06-27 Nalmefene for reduction of alcohol consumption in specific target populations

Publications (2)

Publication Number Publication Date
MX2014015488A MX2014015488A (es) 2015-03-06
MX371373B true MX371373B (es) 2020-01-28

Family

ID=48703496

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014015488A MX371373B (es) 2012-06-27 2013-06-27 Nalmefeno para reducir el consumo de alcohol en poblaciones especificas.

Country Status (35)

Country Link
US (4) US20140005216A1 (OSRAM)
EP (5) EP3138564B1 (OSRAM)
JP (3) JP6258933B2 (OSRAM)
KR (1) KR20150023396A (OSRAM)
CN (1) CN104411313A (OSRAM)
AU (1) AU2013283281B2 (OSRAM)
BR (1) BR112014032555A2 (OSRAM)
CA (1) CA2874703C (OSRAM)
CL (1) CL2014003484A1 (OSRAM)
CO (1) CO7160087A2 (OSRAM)
CY (3) CY1118579T1 (OSRAM)
DK (3) DK3345604T3 (OSRAM)
EA (1) EA029908B1 (OSRAM)
ES (4) ES2950492T3 (OSRAM)
FI (1) FI3345604T3 (OSRAM)
HK (1) HK1255683A1 (OSRAM)
HR (4) HRP20161717T1 (OSRAM)
HU (4) HUE070621T2 (OSRAM)
IL (1) IL236035B (OSRAM)
LT (3) LT3138564T (OSRAM)
ME (2) ME02587B (OSRAM)
MX (1) MX371373B (OSRAM)
MY (1) MY166914A (OSRAM)
NZ (1) NZ702191A (OSRAM)
PH (1) PH12014502798A1 (OSRAM)
PL (4) PL3345604T3 (OSRAM)
PT (3) PT3138564T (OSRAM)
RS (2) RS57046B1 (OSRAM)
RU (1) RU2665373C2 (OSRAM)
SG (1) SG11201408704WA (OSRAM)
SI (3) SI2866808T1 (OSRAM)
SM (3) SMT201800164T1 (OSRAM)
UA (1) UA114199C2 (OSRAM)
WO (1) WO2014001427A1 (OSRAM)
ZA (1) ZA201409525B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140005216A1 (en) 2012-06-27 2014-01-02 H. Lundbeck A/S Nalmefene for reduction of alcohol consumption in specific target populations
WO2014170353A1 (en) * 2013-04-17 2014-10-23 H. Lundbeck A/S Nalmefene for treatment of patients with sleep disorder
JP6797691B2 (ja) 2014-04-22 2020-12-09 大塚製薬株式会社 ブレクスピプラゾールとナルメフェンの組み合わせ剤及び物質関連障害を治療するためのその用途
US20170071590A1 (en) * 2015-09-10 2017-03-16 Suture Armor Llc Suture anchor
KR102699603B1 (ko) 2018-04-20 2024-08-29 삼성전자주식회사 반도체 메모리 소자

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3814768A (en) 1971-11-26 1974-06-04 Lewenstein E 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts
US4535157A (en) 1983-11-01 1985-08-13 Key Pharmaceuticals, Inc. Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone
US5086058A (en) * 1990-06-04 1992-02-04 Alko Ltd. Method for treating alcoholism with nalmefene
WO2003015783A1 (en) * 2001-08-14 2003-02-27 Biotie Therapies Corporation Method of treating alcoholism or alcohol abuse
UA102128C2 (en) 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
PL2435439T3 (pl) 2009-05-25 2016-05-31 H Lundbeck As Wytwarzanie chlorowodorku nalmefenu z naltreksonu
AU2011325563B2 (en) 2010-11-05 2015-08-20 H. Lundbeck A/S Method for the manufacturing of naltrexone
EP2691097B1 (en) 2011-03-31 2017-12-20 Imuneks Farma Ilaç Sanayi Ve Ticaret A.S. Compositions comprising naltrexone for use in treating scleroderma
US20140005216A1 (en) 2012-06-27 2014-01-02 H. Lundbeck A/S Nalmefene for reduction of alcohol consumption in specific target populations

Also Published As

Publication number Publication date
DK3345604T3 (da) 2023-07-24
SMT201600471B (it) 2017-03-08
SI3345604T1 (sl) 2023-08-31
AU2013283281B2 (en) 2017-04-20
PH12014502798A1 (en) 2015-02-09
CN104411313A (zh) 2015-03-11
UA114199C2 (uk) 2017-05-10
IL236035B (en) 2018-12-31
US20140005217A1 (en) 2014-01-02
ME02587B (me) 2017-06-20
EA201492152A1 (ru) 2015-11-30
EA029908B1 (ru) 2018-05-31
SMT201600471T1 (it) 2017-03-08
PL2866808T3 (pl) 2017-04-28
EP3138564B1 (en) 2018-01-31
HUE070621T2 (hu) 2025-06-28
JP6857684B2 (ja) 2021-04-14
ES2609122T3 (es) 2017-04-18
US9642849B2 (en) 2017-05-09
CY1118579T1 (el) 2017-07-12
JP6258933B2 (ja) 2018-01-10
EP4223296B1 (en) 2025-01-29
PL3345604T3 (pl) 2023-08-28
ME03030B (me) 2018-10-20
EP3345604A1 (en) 2018-07-11
JP2018039810A (ja) 2018-03-15
LT3138564T (lt) 2018-04-10
HUE031110T2 (en) 2017-06-28
EP4223296A3 (en) 2023-09-27
PT2866808T (pt) 2017-01-03
EP3138564A1 (en) 2017-03-08
WO2014001427A1 (en) 2014-01-03
HRP20230762T1 (hr) 2023-10-13
EP4541421A2 (en) 2025-04-23
JP2015521647A (ja) 2015-07-30
EP4223296A2 (en) 2023-08-09
SG11201408704WA (en) 2015-01-29
US20180028526A1 (en) 2018-02-01
DK3138564T3 (en) 2018-03-26
EP3345604B1 (en) 2023-06-07
FI3345604T3 (fi) 2023-07-28
RS57046B1 (sr) 2018-05-31
EP2866808A1 (en) 2015-05-06
US20160375007A1 (en) 2016-12-29
RU2014151156A (ru) 2016-08-20
HUE036272T2 (hu) 2018-06-28
CY1120097T1 (el) 2018-12-12
IL236035A0 (en) 2015-01-29
ZA201409525B (en) 2016-08-31
PL4223296T3 (pl) 2025-04-14
EP4541421A3 (en) 2025-06-18
EP2866808B1 (en) 2016-11-02
CL2014003484A1 (es) 2015-02-27
MX2014015488A (es) 2015-03-06
CA2874703C (en) 2022-08-23
CO7160087A2 (es) 2015-01-15
LT2866808T (lt) 2017-01-10
MY166914A (en) 2018-07-24
US10034874B2 (en) 2018-07-31
ES2950492T3 (es) 2023-10-10
PT3345604T (pt) 2023-07-17
AU2013283281A1 (en) 2014-12-11
JP2019163275A (ja) 2019-09-26
HRP20161717T1 (hr) 2017-02-10
HK1255683A1 (en) 2019-08-23
EP4223296C0 (en) 2025-01-29
CA2874703A1 (en) 2014-01-03
KR20150023396A (ko) 2015-03-05
ES3014068T3 (en) 2025-04-16
SI3138564T1 (en) 2018-04-30
HRP20250329T1 (hr) 2025-05-09
HK1208185A1 (en) 2016-02-26
SMT201800164T1 (it) 2018-07-17
CY1126140T1 (el) 2023-11-15
US20140005216A1 (en) 2014-01-02
DK2866808T3 (en) 2017-01-16
LT3345604T (lt) 2023-08-10
RU2665373C2 (ru) 2018-08-29
SI2866808T1 (sl) 2017-01-31
HRP20180363T1 (hr) 2018-04-20
RS55456B1 (sr) 2017-04-28
NZ702191A (en) 2017-06-30
ES2663532T3 (es) 2018-04-13
HRP20230762T8 (hr) 2024-01-05
PT3138564T (pt) 2018-04-03
PL3138564T3 (pl) 2018-06-29
BR112014032555A2 (pt) 2017-06-27
HUE063313T2 (hu) 2024-01-28

Similar Documents

Publication Publication Date Title
AU342950S (en) Utility pump
AU342351S (en) Automobile
AU338331S (en) Handle
AU341123S (en) Oil pan
CY1126140T1 (el) Ναλμεφενη για τη μειωση της καταναλωσεως αλκοολης σε συγκεκριμενους πληθυσμους στοχους
AU342936S (en) Insole
GB201102108D0 (en) Diagnostic method
UA117567C2 (uk) Композиція, яка стимулює лактацію, на основі фосфатидилсерину
AU338318S (en) Latch
MX2013005759A (es) Metodos para detectar bajo grado de inflamacion.
AU338332S (en) Handle
AU344993S (en) Toilet pan
Fronek et al. An apology to forced adoption birth mothers: it's about time.
CA144989S (en) Adapter for firearms
UA106373C2 (ru) Применение поллентара как средства фригопротекторного действия
AU349260S (en) Refill for device
AU341441S (en) Soles
AU340249S (en) Soles
AU340248S (en) Soles

Legal Events

Date Code Title Description
FG Grant or registration